Md Masud Alam Selected Research

HMGN1 Protein (HMGN1)

10/2023	Reactive Oxygen Species-Sensitive Biodegradable Mesoporous Silica Nanoparticles Harboring TheraVac Elicit Tumor-Specific Immunity for Colon Tumor Treatment.
1/2023	A Therapeutic Vaccine in Combination with Cyclic GMP-AMP Cures More Differentiated Melanomas in Mice.
12/2021	A TNFR2 antibody by countering immunosuppression cooperates with HMGN1 and R848 immune stimulants to inhibit murine colon cancer.
1/2018	High-mobility group nucleosome binding domain 1 (HMGN1) functions as a Th1-polarizing alarmin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Md Masud Alam Research Topics

Disease

6	Neoplasms (Cancer) 01/2024 - 01/2018
2	Melanoma (Melanoma, Malignant) 01/2024 - 01/2023
2	Colonic Neoplasms (Colon Cancer) 10/2023 - 12/2021
2	Infections 05/2021 - 01/2021
2	Primary Effusion Lymphoma 03/2021 - 12/2014
2	Diarrhea 01/2021 - 10/2018
1	Colorectal Neoplasms (Colorectal Cancer) 10/2023
1	Bites and Stings (Sting) 01/2023
1	Parkinson Disease (Parkinson's Disease) 11/2022
1	Communicable Diseases (Infectious Diseases) 01/2022
1	Genetic Predisposition to Disease (Genetic Predisposition) 05/2021
1	Bacillary Dysentery (Shigellosis) 01/2021
1	Inflammation (Inflammations) 10/2018
1	Poliomyelitis (Polio) 10/2018
1	Acquired Immunodeficiency Syndrome (AIDS) 12/2014
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 12/2014

Drug/Important Bio-Agent (IBA)

4	VaccinesIBA 10/2023 - 10/2018
4	HMGN1 Protein (HMGN1)IBA 10/2023 - 01/2018
2	AlarminsIBA 01/2024 - 01/2018
1	LTX-315IBA 01/2024
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2024
1	AntigensIBA 01/2024
1	DNA (Deoxyribonucleic Acid)IBA 01/2024
1	RNA (Ribonucleic Acid)IBA 01/2024
1	Nucleic AcidsIBA 01/2024
1	Silicon Dioxide (Silica)FDA LinkGeneric 10/2023
1	resiquimodIBA 10/2023
1	Carrier Proteins (Binding Protein)IBA 10/2023
1	Nucleosomes (Nucleosome)IBA 10/2023
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2023
1	Immune Checkpoint InhibitorsIBA 01/2023
1	CytokinesIBA 01/2023
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2023
1	Melanins (Melanin)IBA 01/2023
1	alpha-SynucleinIBA 11/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	Type II Tumor Necrosis Factor ReceptorsIBA 12/2021
1	Indicators and Reagents (Reagents)IBA 12/2021
1	HLA Antigens (Human Leukocyte Antigens)IBA 05/2021
1	shikoninIBA 03/2021
1	Azithromycin (Zithromax)FDA LinkGeneric 01/2021
1	C-Reactive ProteinIBA 10/2018
1	CholesterolIBA 12/2014
1	CyclodextrinsIBA 12/2014
1	LipidsIBA 12/2014

Therapy/Procedure

4	Immunotherapy 10/2023 - 01/2018
1	Therapeutics 10/2023
1	Drug Therapy (Chemotherapy) 12/2014